Most questions about when to take a supplement assume there is a best hour to catch its effect. Lion's mane doesn't fit that pattern well. Nearly all of its human research tested daily use over weeks, and we found no trial that compared morning with evening doses, or doses taken with and without food (PubMed search, October 2026). What the trials did do still points to a sensible default, and a few choices matter more than the time on the clock.

This article is educational and is not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a qualified clinician before starting anything new, especially if you have a mushroom allergy, take a blood thinner, antiplatelet or diabetes medication, or are pregnant or breastfeeding.

The short answer

Take it at a time you will remember every day, with or after a meal if it bothers your stomach. The longer trials measured their results after weeks of daily use, and none of them tested whether the time of day changed the outcome. Morning is a reasonable default, and one recent trial used exactly that: three capsules every morning after breakfast (Docherty 2023). Nothing in the research says an evening dose is a problem.

What the longer trials did

  • Mori et al. (2009) randomized 30 adults aged 50 to 80 with mild cognitive impairment to lion's mane or a placebo. The lion's mane group took four 250 mg tablets of the dried mushroom powder three times a day, about 3 g a day, for 16 weeks. Their cognitive scores were significantly higher than the placebo group's at weeks 8, 12 and 16, and fell again within four weeks of stopping.
  • Saitsu et al. (2019) gave 31 adults over 50 with normal cognition 3.2 g a day of fruiting-body powder, or a placebo, for 12 weeks. Scores on a general cognitive screening test (the Mini-Mental State Examination) ended higher than placebo, at the top of its scale, while two memory tests showed no difference.
  • Li et al. (2020) gave people with mild Alzheimer's disease three capsules a day of a mycelium extract enriched in erinacine A, or a placebo, for 49 weeks. Four people dropped out because of abdominal discomfort, nausea or a skin rash.
  • Docherty et al. (2023) gave 41 healthy adults aged 18 to 45 either 1.8 g of lion's mane a day, as three 600 mg capsules every morning after breakfast, or a placebo for 28 days. Over the 28 days the results were mostly null, with a trend toward lower self-reported stress that fell just short of statistical significance.
  • Grozier et al. (2022) gave 24 college-age adults 10 g a day baked into two muffins, or placebo muffins, for four weeks, and found no effect on any cognitive measure.
The common thread is daily use for weeks, mostly at 1 to 3 g a day, which is more than many 500 to 1,000 mg capsule products provide. None of these trials tested whether the time of day changes the result.

What the single-dose studies found

Three small trials gave a single dose and tested people soon afterward. They are the closest thing to timing data that exists, and they found little.

  • Docherty et al. (2023): on the first test day, participants ate a standard breakfast no later than an hour before arriving, then took 1.8 g or a placebo and were tested 60 minutes later. The lion's mane group was faster on one attention task, the Stroop test, and the authors also reported null and some negative results.
  • La Monica et al. (2023): participants arrived after an 8-hour fast, took 1 g, and were tested at one and two hours. Some reaction-time and working-memory scores improved over time within the lion's mane condition, but those changes did not show that it beat placebo.
  • Surendran et al. (2025): 18 young adults took 3 g of a concentrated fruiting-body extract on one visit and a placebo on another, and were tested 90 minutes after each. There was no overall effect on cognition or mood, and one fine-motor test improved.

Those results are too small and inconsistent to show a same-day effect, and they can't tell you when lion's mane peaks in the body. The 2025 trial's authors list the time it takes lion's mane's active compounds to peak in the human brain as a question future research still needs to answer.

Get The Signal by email. New research, grade changes and safety notes, about every two weeks. Subscribe free

Morning or night?

We found no trial that compared morning with evening dosing. Lion's mane is not a stimulant, and the two studies we found that measured sleep don't suggest it disrupts it. A placebo-controlled trial in 30 women that measured sleep quality over four weeks did not report a sleep effect (Nagano 2010). A study in adults with overweight on a low-calorie diet reported better sleep-quality scores after eight weeks, but it compared lion's mane with the diet alone rather than with a placebo, so the improvement can't be credited to the mushroom (Vigna 2019). In practice, morning works well if you want to mirror the most recent trial, and evening is fine if that is when you will remember. If you notice it affects your sleep, move it earlier.

With food or on an empty stomach?

Here too, we found no trial that compared the two. The single-dose studies went both ways: one tested people about an hour after a light breakfast (Docherty 2023), another after an 8-hour fast (La Monica 2023), and the 28-day phase of the 2023 trial had people take their capsules after breakfast. Since most of the side effects that made people stop in the longest trial were digestive (Li 2020), taking lion's mane with or after a meal is a sensible way to avoid an upset stomach. That is a comfort choice, not something shown to change how well it works.

Daily, and for how long

Consistency matters more than timing. In the 16-week trial, the difference from placebo was significant at weeks 8, 12 and 16, and scores fell again within four weeks of stopping (Mori 2009). Most of the more recent trials ran for 4 to 12 weeks, and the shortest ones mostly found nothing. A fair test means a studied form, taken every day for 8 to 12 weeks, with modest expectations. The overall evidence is still at an early stage, which is why our profile grades lion's mane Emerging.

What you take matters more than when

  • Form: some trials used the fruiting body (the mushroom itself), others mycelium extracts, and they are different products. A result for one doesn't automatically carry over to the other.
  • Dose: the trials mostly used 1 to 3 g a day, while many capsule products provide 500 to 1,000 mg.
  • Label: prefer a fruiting-body product that states its beta-glucan content. A high total-polysaccharide figure on mycelium grown on grain can be largely starch.

Before you start

  • Mushroom allergy: avoid lion's mane. Allergic reactions are its best-documented risk, including a reported case of a severe lung reaction (Nakatsugawa 2003). Stop and seek care if you develop breathing problems or a rash.
  • Blood thinners, antiplatelet drugs or diabetes medication: no human interaction study exists, but lab and animal findings on platelets and blood sugar are a reason to tell your prescriber first.
  • Pregnancy or breastfeeding: not studied, so check with your clinician.
Where each interaction warning comes from, how much weight it carries, and what to ask your prescriber. Lion's mane drug interactions

The bottom line

We found no trial that tested a best time of day for lion's mane, so there isn't one to follow. Take a studied form at a studied dose at the same time every day, with food if your stomach prefers it, and judge it after 8 to 12 weeks rather than the same afternoon. The single-dose studies found little, and the long-term evidence is small enough that modest expectations are the honest ones.

Evidence grade, studied doses, every trial we found (including the null ones) and the cautions, in one place. See the full lion's mane profile

References

This article draws on the primary human research below; see the linked studies for full methods and doses.

  • Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial." Phytotherapy Research, 2009;23(3):367–372. PMID: 18844328.
  • Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. "Improvement of cognitive functions by oral intake of Hericium erinaceus." Biomedical Research, 2019;40(4):125–131. PMID: 31413233.
  • Li IC, Chang HH, Lin CH, et al. "Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study." Frontiers in Aging Neuroscience, 2020;12:155. PMID: 32581767.
  • Docherty S, Doughty FL, Smith EF. "The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study." Nutrients, 2023;15(22):4842. PMID: 38004235.
  • La Monica MB, Raub B, Ziegenfuss EJ, et al. "Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance." Nutrients, 2023;15(24):5018. PMID: 38140277.
  • Surendran G, Saye J, Binti Mohd Jalil S, et al. "Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study." Frontiers in Nutrition, 2025;12:1405796. PMID: 40276537.
  • Grozier CD, Alves VA, Killen LG, et al. "Four Weeks of Hericium erinaceus Supplementation Does Not Impact Markers of Metabolic Flexibility or Cognition." International Journal of Exercise Science, 2022;15(2):1366–1380. PMID: 36582308.
  • Nagano M, Shimizu K, Kondo R, et al. "Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake." Biomedical Research, 2010;31(4):231–237. PMID: 20834180.
  • Vigna L, Morelli F, Agnelli GM, et al. "Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?" Evidence-Based Complementary and Alternative Medicine, 2019;2019:7861297. PMID: 31118969.
  • Nakatsugawa M, Takahashi H, Takezawa C, et al. "Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins." Internal Medicine, 2003;42(12):1219–1222. PMID: 14714963.